Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$600K Sell
15,700
-10,800
-41% -$342K ﹤0.01% 952
2025
Q4
$578K Buy
26,500
+15,100
+132% +$314K ﹤0.01% 957
2025
Q3
$245K Buy
11,400
+11,300
+11,300% +$253K ﹤0.01% 1438
2025
Q2
$2.56K Hold
100
﹤0.01% 2191
2025
Q1
$3.66K Hold
100
﹤0.01% 1901
2024
Q4
$3.07K Hold
100
﹤0.01% 1869
2024
Q3
$3.77K Hold
100
﹤0.01% 1952
2024
Q2
$3.96K Hold
100
﹤0.01% 1939
2024
Q1
$3K Hold
100
﹤0.01% 1902
2023
Q4
$3K Sell
100
-17,800
-99% -$574K ﹤0.01% 1894
2023
Q3
$561K Buy
+17,900
New +$563K ﹤0.01% 1188
2015
Q3
Sell
-4,200
Closed -$137K 1879
2015
Q2
$176K Buy
+4,200
New +$198K ﹤0.01% 1584

Other funds holding ATEX

STRS Ohio's ATEX Position: Q1 2026 in Review

STRS Ohio reduced its Anterix (ATEX) stake by 41% in Q1 2026, selling an estimated $342K and leaving 15,700 shares worth $600K. The position accounts for ﹤0.01% of the portfolio, ranked #952.

STRS Ohio first reported a position in ATEX in Q2 2015 and has held it in 12 quarters since. 132 funds tracked by Wall St. Rank hold ATEX as of Q1 2026.

  • STRS Ohio held 15,700 shares of Anterix worth $600K as of Q1 2026.
  • STRS Ohio sold 10,800 Anterix shares in Q1 2026, an estimated $342K.
  • Anterix made up ﹤0.01% of STRS Ohio's portfolio in Q1 2026, its #952 holding.
  • STRS Ohio first reported a position in Anterix in Q2 2015 and has held it in 12 quarters since.
  • 132 funds tracked by Wall St. Rank held Anterix as of Q1 2026.

Based on STRS Ohio's 13F filing for Q1 2026, filed 24 Apr 2026.